Drug Names Feb 22, 2022 FDA Approves Foundation Medicine Test as CDx for Merck's Keytruda to Identify MSI-H Solid Tumors Feb 9, 2022 Foundation Medicine, Eli Lilly Ink CDx Development Deal for Retevmo Dec 8, 2021 Foundation Medicine Test Nabs FDA Approval as CDx for BRAF Inhibitor Therapeutics for Melanoma Sep 7, 2021 Illumina, Merck Partner to Advance Homologous Recombination Deficiency CDx, Research Assay Aug 17, 2021 Amoy Diagnostics CDx Gets Japanese Approval to ID NSCLC Patients Eligible for Tepmetko Jul 16, 2021 FDA Approves Foundation Medicine's Liquid Biopsy Test as CDx for Novartis' Tabrecta in NSCLC Jul 1, 2021 FDA Approves FoundationOne CDx for Takeda's ALK-Inhibitor Jun 14, 2021 Genecast to Evaluate Liquid Biopsy EGFR Mutation Test in Early-Stage Non-Small Cell Lung Cancer May 26, 2021 23andMe Begins Reporting PGx Variants With Drug Info Under Recent FDA Clearance Premium Apr 12, 2021 Oncocyte AACR Data Expands Potential Applications for Immunotherapy Response Predictor Mar 18, 2021 Oncocyte Details New Expansions Plans With Growing Portfolio of Acquired Tests Premium Mar 4, 2021 FDA Expands Approval of Pfizer's Lorbrena to First-Line ALK-Positive NSCLC; Approves Roche CDx Feb 26, 2021 Natera Launches Tumor Genomic Profiling Assay, Expects Reproductive Health to Break Even This Year Premium Jan 20, 2021 Biotheranostics' Breast Cancer Index Included in Latest NCCN Guidelines Jan 4, 2021 Castle Bio, NantHealth Pace Gainers as 360Dx Index Climbs 4 Percent in December Dec 23, 2020 Amoy Diagnostics, Merck KGaA Partner for Lung Cancer Companion Diagnostic Development in China Dec 10, 2020 Tempus Raises $200M in Series G2, Inks Oncology Testing Collaboration With Bayer Nov 16, 2020 Myriad Genetics Expands MyChoice CDx Access Through Partnerships in Europe, China Nov 13, 2020 FDA Approves Merck's Keytruda, Agilent CDx in PD-L1-High Triple-Negative Breast Cancer Nov 9, 2020 FDA Approves Foundation Medicine Liquid Biopsy Test as CDx for Lynparza Load More Breaking News MiRxes Launches Study for Pulmonary Hypertension Biomarkers in Asian Populations OraSure Technologies Awarded $8.6M BARDA Contract for Next-Gen Ebola Test BioAffinity Technologies Nabs $15.6M from Public Offering Taiwanese Dx Firm Micronbrane Medical Closes $4.5M Series A Financing Round Thermo Fisher Gets FDA OK for CDx Test to Guide Use of Lilly Drug in Lung, Thyroid Cancers FDA Updates COVID-19 Test Emergency Use Authorization Policy
